Amgen has the resources to help Mannkind make Afrezza a global mega $ blockbuster and expand Technosphere Drug Development Pipeline targeting many new inhaled drug candidates. Wonder if they are interested and or have been speaking to Mannkind. Michael Castagna left Amge in 2016 to work for Mannkind and is now CEO. Other former Amgen executives have also been hired by Mannkind.
Except for David Chang (Kite Pharma) any other former Amgen "executive" will bring DOOM to your company you moron.
It is about the patient, Afrezza will be the new standard of care for diabetes, Endos will get over 5 min test. PCP and other resources can administer tests.
Agreed. Worked with David and he was one of the very few at Amgen that could be called a business leader. Castagna is a disaster at all companies he has fooled with his PharmD and commercial experience. Same fate for Mannkind. Avoid this next disaster. Mannkind has a few months of cash remaining and will be bankrupt in 2018.
Castagna was a disaster at BMS and fucked the Orencia team. Tony Hooper likes him so he got hired here as a VP. Mannkind is on life support and once the cash is done, it’s over. David Chang made $121M off Kite sale. He will likely be looking for. CEO roles or will be an investor.
